Pacific Diabetes Technologies (PDT) is dedicated to the goal of creating an accessible integrated artificial pancreas by combining insulin infusion and sensor chemistry.
Not only will these devices make life simpler for people with Type 1 diabetes or insulin-treated Type 2 diabetes, they can be instrumental in bringing a reliable artificial pancreas to market.
THESE DEVICES ARE NOT YET APPROVED FOR HUMAN USE.
This integrated solution combines multiple amperometric glucose sensing units with insulin delivery in a single unified device that is ideal for diabetes management. For the price of a CGM sensor, PDT’s solution is to deliver both continuous glucose sensing as well as insulin infusion.